These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7536507)

  • 1. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.
    Shrestha P; Sumitomo S; Ogata K; Yamada K; Takai Y; Yang L; Mori M
    Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):393-9. PubMed ID: 7536507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenascin in salivary gland tumours.
    Soini Y; Pääkkö P; Virtanen I; Lehto VP
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 expression in salivary gland tumours.
    de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
    Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
    Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
    BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
    Lee CH; Lee SK; Chi JG; Park SC; Chung SI; Saitoh M; Shrestha P; Mori M
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):401-6. PubMed ID: 9039224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial membrane antigen and DOG1 expression in minor salivary gland tumours.
    Andrade EP; Teixeira LN; Montalli VAM; Garcia FM; Passador-Santos F; Soares AB; Araújo VC
    Ann Diagn Pathol; 2019 Dec; 43():151408. PubMed ID: 31629156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Expression of Mucin in Salivary Gland Tumours.
    Mahamad Apandi NI; Chan SW; Toh YF
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929537
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of PLUNC family members in benign and malignant salivary gland tumours.
    Vargas PA; Speight PM; Bingle CD; Barrett AW; Bingle L
    Oral Dis; 2008 Oct; 14(7):613-9. PubMed ID: 18221458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
    Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
    Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
    Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
    Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTcO4- accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors.
    Akai A; Yamamura Y; Nonaka M; Yoshihara T
    Auris Nasus Larynx; 2014 Dec; 41(6):532-8. PubMed ID: 25199743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
    Mannweiler S; Beham A; Langner C
    APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
    Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin expression in salivary gland tumours.
    Darling MR; Gauthier M; Jackson-Boeters L; Daley TD; Chambers AF; Tuck AB
    Oral Oncol; 2006 Apr; 42(4):363-9. PubMed ID: 16321564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
    Sunardhi-Widyaputra S; Van Damme B
    Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.